We are live on ! Find out more
PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings

AUM $73.6M
1-Year Est. Return 61.93%
This Fund
S&P 500
This Quarter Est. Return
+51.52%
1 Year Est. Return
+61.93%
3 Year Est. Return
+167.56%
5 Year Est. Return
+341.85%
10 Year Est. Return
+2,192.73%
AUM
$178M
AUM Growth
+$48.4M
Cap. Flow
+$627K
Cap. Flow %
0.35%
Top 10 Hldgs %
86.12%
Holding
23
New
2
Increased
2
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$6.01M
2
ELV icon
Elevance Health
ELV
+$5.5M
3
AEM icon
Agnico Eagle Mines
AEM
+$581K
4
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$31.8K

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$4.2M
2
WPX
WPX Energy, Inc.
WPX
+$2.12M
3
AGI icon
Alamos Gold
AGI
+$1.16M
4
CI icon
Cigna
CI
+$917K
5
PBPB
Potbelly
PBPB
+$668K

Sector Composition

Rank Sector Weight
1 Healthcare 54.07%
2 Energy 21.63%
3 Materials 19.64%
4 Technology 2.11%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
1
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$45.4M 25.5%
222,000
-23,000
-9% -$4.2M
HUM icon
2
Humana
HUM
$46.7B
$18.3M 10.3%
50,000
– –
OXY icon
3
Occidental Petroleum
OXY
$58.5B
$16.5M 9.26%
400,000
+150,000
+60% +$6.01M
NEM icon
4
Newmont
NEM
$124B
$15.2M 8.55%
350,000
– –
NVGS icon
5
Navigator Holdings
NVGS
$1.26B
$13.8M 7.75%
1,023,300
– –
ABBV icon
6
AbbVie
ABBV
$440B
$13.3M 7.46%
150,000
– –
CI icon
7
Cigna
CI
$73.3B
$10.2M 5.75%
50,000
-5,000
-9% -$917K
B
8
Barrick Mining
B
$67.9B
$9.29M 5.22%
500,000
– –
ELV icon
9
Elevance Health
ELV
$86.6B
$6.04M 3.39%
+20,000
New +$5.5M
AEM icon
10
Agnico Eagle Mines
AEM
$93.8B
$5.24M 2.94%
85,000
+10,000
+13% +$581K
WPM icon
11
Wheaton Precious Metals
WPM
$61.3B
$5.21M 2.93%
175,000
– –
PARR icon
12
Par Pacific Holdings
PARR
$3.9B
$4.65M 2.61%
200,000
– –
DHX icon
13
DHI Group
DHX
$166M
$3.76M 2.11%
1,250,000
-48,634
-4% -$165K
EPSN icon
14
Epsilon Energy
EPSN
$180M
$3.58M 2.01%
1,085,000
– –
IRIX icon
15
IRIDEX
IRIX
$15.1M
$2.94M 1.65%
1,320,000
– –
ESXB
16
DELISTED
Community Bankers Trust Corporation
ESXB
$2.22M 1.25%
250,000
– –
TUES
17
DELISTED
Tuesday Morning Corp
TUES
$303K 0.17%
163,709
– –
FOMX
18
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$33K 0.02%
+10,000
New +$31.8K
AGI icon
19
Alamos Gold
AGI
$14B
– –
-200,000
Closed -$1.16M
PBPB
20
DELISTED
Potbelly
PBPB
– –
-153,200
Closed -$668K
WPX
21
DELISTED
WPX Energy, Inc.
WPX
– –
-200,000
Closed -$2.12M
NVTR
22
DELISTED
Nuvectra Corporation Common Stock
NVTR
– –
-200,000
Closed -$272K

Similar funds

TWM
Tripletail Wealth Management Orlando, Florida $73.4M AUM 26.64% 1-Year Est. Return
JCA
January Capital Advisors San Francisco, California $74.2M AUM
WH
Wallace Hart Lexington, Kentucky $72.6M AUM 34.63% 1-Year Est. Return
WPA
Winning Points Advisors Boca Raton, Florida $74.8M AUM
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $72M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $75.2M AUM 15.62% 1-Year Est. Return
OC
Owlhouse Capital New York $75.3M AUM
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's Q4 2019 Portfolio in Review

As of Q4 2019, Paragon Associates & Paragon Associates II Joint Venture held 23 positions worth $178M, up 37% from $130M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Paragon Associates & Paragon Associates II Joint Venture's Q4 2019 filing shows 2 new, 2 increased, 3 reduced and 4 closed positions. Its largest new stake was Elevance Health: 20,000 shares worth $6.04M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $4.2M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 42% a quarter earlier, followed by Energy and Materials.

  • Paragon Associates & Paragon Associates II Joint Venture's largest Q4 2019 buy was Elevance Health: 20,000 shares worth $6.04M.
  • Paragon Associates & Paragon Associates II Joint Venture added most to Occidental Petroleum in Q4 2019, an estimated $6.01M increase.
  • Paragon Associates & Paragon Associates II Joint Venture's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $4.2M.
  • Paragon Associates & Paragon Associates II Joint Venture fully exited WPX Energy, Inc. in Q4 2019, selling an estimated $2.12M.
  • Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 86% of its $178M portfolio in Q4 2019.
  • Paragon Associates & Paragon Associates II Joint Venture opened 2 new positions and closed 4 in Q4 2019.
  • Paragon Associates & Paragon Associates II Joint Venture's portfolio value rose 37% quarter-over-quarter to $178M.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q4 2019, filed 13 Feb 2020.